Thursday, September 22, 2011

StemCells Inc. treats 1st spinal cord patient with neural stem cells

Neural stem cells developed by Newark’s StemCells Inc. were transplanted Wednesday into a spinal cord injury patient, the first person treated in a Phase I/II trial.
The procedure, led by Dr. Raphael Guzman, a neurosurgeon and Stanford University faculty member, was performed at Balgrist University Hospital at the University of Zurich in Switzerland.

No comments:

Post a Comment